FI972415L - Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä - Google Patents

Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä Download PDF

Info

Publication number
FI972415L
FI972415L FI972415A FI972415A FI972415L FI 972415 L FI972415 L FI 972415L FI 972415 A FI972415 A FI 972415A FI 972415 A FI972415 A FI 972415A FI 972415 L FI972415 L FI 972415L
Authority
FI
Finland
Prior art keywords
micelle
release
controlled
composition forming
normal
Prior art date
Application number
FI972415A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972415A7 (fi
FI972415A0 (fi
Inventor
Kaore Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of FI972415A7 publication Critical patent/FI972415A7/fi
Publication of FI972415A0 publication Critical patent/FI972415A0/fi
Publication of FI972415L publication Critical patent/FI972415L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
FI972415A 1994-12-09 1995-12-08 Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä FI972415L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin
PCT/SE1995/001479 WO1996017597A1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure

Publications (3)

Publication Number Publication Date
FI972415A7 FI972415A7 (fi) 1997-06-06
FI972415A0 FI972415A0 (fi) 1997-06-06
FI972415L true FI972415L (fi) 1997-06-06

Family

ID=20396276

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972415A FI972415L (fi) 1994-12-09 1995-12-08 Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä

Country Status (13)

Country Link
US (1) US5906831A (de)
EP (1) EP0790822B1 (de)
JP (1) JP3487860B2 (de)
AT (1) ATE213932T1 (de)
AU (1) AU4276896A (de)
BR (1) BR9509897A (de)
CA (1) CA2207218C (de)
DE (1) DE69525761T2 (de)
ES (1) ES2170171T3 (de)
FI (1) FI972415L (de)
NO (1) NO972614D0 (de)
SE (1) SE518619C2 (de)
WO (1) WO1996017597A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
CA2466432A1 (en) * 2001-11-08 2003-05-15 Atrium Medical Corporation Intraluminal device with a coating containing a therapeutic agent
JP2005515197A (ja) * 2001-12-03 2005-05-26 ドー バイオファーマ インコーポレイテッド 安定化された逆ミセル組成物およびその使用
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
EP1812022B1 (de) 2004-09-28 2014-01-15 Atrium Medical Corporation Alleinstehende folie und verfahren zu ihrer herstellung
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
WO2006036970A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Method of thickening a coating using a drug
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036967A1 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Solubilizing a drug for use in a coating
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
JP2009511215A (ja) 2005-10-15 2009-03-19 アトリウム メディカル コーポレーション 生体吸収性薬物担体コーティング用の疎水性架橋ゲル
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
EP2083875B1 (de) 2006-11-06 2013-03-27 Atrium Medical Corporation Beschichtetes chirurgisches netz
CA2988753A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
JP5767103B2 (ja) * 2008-05-21 2015-08-19 フエリング・インターナシヨナル・センター・エス・アー 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN107709349B (zh) 2015-05-20 2022-01-28 阿比尔技术公司 植物提取物组合物和制备其的方法
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10266708B2 (en) 2015-09-16 2019-04-23 Apeel Technology, Inc. Precursor compounds for molecular coatings
CN112841185A (zh) 2015-12-10 2021-05-28 阿比尔技术公司 用于形成保护性涂层的植物提取物组合物
CN109068627B (zh) 2016-01-26 2022-03-18 阿比尔技术公司 用于制备和保存消毒产品的方法
EP3541192B1 (de) 2016-11-17 2025-06-25 Apeel Technology, Inc. Verfahren zur herstellung von fettsäure-estern aus vernetzten polyestern
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
CA3107214A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease
US12245605B2 (en) 2018-09-05 2025-03-11 Apeel Technology, Inc. Compounds and formulations for protective coatings
WO2021178553A1 (en) 2020-03-04 2021-09-10 Apeel Technology, Inc. Coated agricultural products and corresponding methods
WO2022094339A1 (en) 2020-10-30 2022-05-05 Apeel Technology, Inc. Compositions and methods of preparation thereof
KR20230101840A (ko) 2020-11-04 2023-07-06 인올렉스 인베스트먼트 코포레이션 바이오 기반 글리세릴 헵타노에이트 에스테르 조성물, 이를 제조 및 사용하는 방법
WO2023039077A1 (en) 2021-09-08 2023-03-16 Apeel Technology, Inc. Compounds and formulations for protective coatings

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Also Published As

Publication number Publication date
EP0790822B1 (de) 2002-03-06
SE518619C2 (sv) 2002-10-29
WO1996017597A1 (en) 1996-06-13
CA2207218C (en) 2002-02-12
JP3487860B2 (ja) 2004-01-19
ATE213932T1 (de) 2002-03-15
DE69525761T2 (de) 2002-10-24
ES2170171T3 (es) 2002-08-01
FI972415A7 (fi) 1997-06-06
DE69525761D1 (de) 2002-04-11
US5906831A (en) 1999-05-25
SE9404289D0 (sv) 1994-12-09
JPH10510260A (ja) 1998-10-06
NO972614L (no) 1997-06-06
AU4276896A (en) 1996-06-26
CA2207218A1 (en) 1996-06-13
NO972614D0 (no) 1997-06-06
FI972415A0 (fi) 1997-06-06
BR9509897A (pt) 1997-12-30
SE9404289L (sv) 1996-06-10
EP0790822A1 (de) 1997-08-27

Similar Documents

Publication Publication Date Title
FI972415L (fi) Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä
FI953489A0 (fi) 2,6-diaminopuriinijohdannaisia
MA23780A1 (fr) Quinazolinones 2, 8 disubstitues
FI961809L (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
DE69423159D1 (de) Kombinierter Entzerrer/Demultiplexer
EP0678788A3 (de) Nicht korrosives Photolackentschichtungsmittel.
DE69618634D1 (de) 1,4-benzodioxin-derivate
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
FR2690531B1 (fr) Microscope operatoire.
DE59607589D1 (de) N-aryl-1,2,4-triazolin-5-one
FI970081L (fi) Dinukleosidi-5',5'-pyrofosfaatit
DE59608566D1 (de) Rektoskop
EP0811014A4 (de) Neuartiges bakteriozin, piscicolin 126
EP0614062A3 (de) Expandierte Strukturen.
DE59403739D1 (de) Nichtionische emulgatoren
FR2708456B1 (fr) Ecarteur.
FI961594A0 (fi) Multipleksointi/demultipleksointiyksikkö
FI963615A0 (fi) Peptidit, jotka estävät pepsiinin vapautumisen
FR2724962B3 (fr) Tuile d'avant-toit sous-faitiere.
NO944024D0 (no) 1,2-dihydro-2-okso-pyridin
NL1004200A1 (nl) Hulpstukkoppeling.
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
NO943791D0 (no) 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin
NO942212D0 (no) 13,14-dihydro-PGF2
SE9502141D0 (sv) Låsanordning